Johnson & Johnson to pay $2.2 billion to resolve U.S. probes
Monday, November 04, 2013 - 00:43
Nov. 4 - Settlement ends criminal and civil investigations into false marketing of drugs and kickbacks to doctors and pharmacists. Rough Cut (no reporter narration).
▲ Hide Transcript
▶ View Transcript
U.S. Attorney General Eric Holder announced on Monday that Johnson & Johnson (J&J) will pay $2.2 billion to the U.S. government to resolve criminal and civil probes.
The investigations center around claims that the company and its subsidiaries marketed prescription drugs for off-label uses and that they paid kickbacks to doctors and pharmacists for prescribing the drugs.
"The alleged conduct is shameful and it is unacceptable. It displayed a reckless indifference to the safety of the American people and it constituted a clear abuse of the public trust," Holder said.
The settlement with J&J and its subsidiaries covers the marketing of the anti-psychotic drug, Risperdal, and the heart drug, Natrecor.
Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code